摘要
目的 探讨斑块切除治疗股腘动脉TosakaⅢ型支架内再狭窄的临床疗效.方法 总结首都医科大学宣武医院血管外科2013年6月至2015年12月治疗的33例股腘动脉TosakaⅢ型支架内再狭窄患者的临床资料,分析该组病例的手术成功率、并发症发生率、术后症状和客观指标改善情况、靶血管通畅率.结果 至2016年1月,平均随访时间17.9个月,失访5例,完成随访28例,随访率84.9％.本组病例手术成功率为100％;靶血管一期通畅率,术后6个月为79.9％,术后一年为65.8％.结论 斑块切除治疗股腘动脉TosakaⅢ型支架内再狭窄安全有效,具有良好的近期和中期疗效.
Objective o investigate the clinical efficacy of atherectomy in the treatment of Tosaka class Ⅲ in-stent restenosis in the femoropopliteal artery. Methods From June 2013 to December 2015, 33 restenotic lesions after femoropopliteal artery stenting were retrospectively analyzed by clinical information including technical success rate, incidence of complications, improvement of postoperative symptoms and objective indicators, and target vessel patency. Results To January 2016, twenty-eight cases were followed up. The average follow-up time was 17. 9 months. Five cases were lost. The follow-up rate was 84. 9％. The technical success rate was 100％. The patency rate was 79. 9％ at 6 months and 65. 8％ at 1 year after surgery. Conclusions Atherectomy is safe and effective for treatment of Tosaka classⅢin-stent restenosis in femoropopliteal artery with good short-term and medium-term efficacy.
出处
《中国医师杂志》
CAS
2017年第12期1776-1778,共3页
Journal of Chinese Physician
基金
北京市医管局临床技术创新项目(XMLX201610)%北京市医院管理局登峰人才培育计划(DFL20150801)%首都卫生发展科研专项(2016-1-2012)%国家重点研发计划(2017YFC1104100)%北京市卫生系统高层次卫生技术人才培养计划-学科骨干(2014-3-059)%宣武医院英才培养计划第一、三层次%北京市优秀人才培养青年骨干个人项目(2016000020124G108)%北京市属医院科研培育计划(PX2018035)%北京中医科技发展基金项目(JJ2015-09)%首都全科医学研究专项(17QK10)Fund program:Beijing Municipal Administration of Hospitals Clinical Technology Innovation Project(XMLX201610)%Beijing Municipal Administration of Hospitals Dengfeng Training Plan(DFL20150801)%Capital Health Development Research Projects(2016-1-2012)%National Key Development Program(2017YFC1104100)%Beijing Health System Plan and Discipline Backbone Training High-Level Health Technical Personnel(2014-3-059)%Xuanwu Hospital Personnel Training First and Third Level%Beijing Ex-cellent Talent Project(2016000020124G108)%Beijing Municipal Administration of Hospitals Incubating Program(PX2018035)%Beijing Chinese Medical Science and Technique Development Foundation Project(JJ2015-09)%Beijing General Medical Research Project(17QK10)
